FATE THERAPEUTICS INC — Director's Dealing 2020

Oct 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2020-10-01

Reporting Person: TAHL CINDY (General Counsel and Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-01	Common stock	M	35000	$2.73	Acquired	134518	Direct
2020-10-01	Common stock	S	21757	$40.2584	Disposed	112761	Direct
2020-10-01	Common stock	S	6260	$41.0917	Disposed	106501	Direct
2020-10-01	Common stock	S	6983	$41.9489	Disposed	99518	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-01	Stock Option (right to buy)	$2.73	M	35000	Disposed	2027-01-03	Common Stock (35000)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020.

F2: Represents the weighted average sale price of the shares sold ranging from $39.65 to $40.63 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.

F3: Represents the weighted average sale price of the shares sold ranging from $40.65 to $41.63 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.

F4: Represents the weighted average sale price of the shares sold ranging from $41.66 to $42.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.

F5: The shares subject to this option shall vest and become exercisable in 48 monthly installments beginning on February 4, 2017 such that this option is fully exercisable on January 4, 2021.

F6: Not applicable.